Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company dedicated to creating small molecule drugs for the treatment of viral infections and liver diseases. Though US based, Enanta’s products address unmet medical needs worldwide.
As part of the biotech sector, Enanta Pharmaceuticals has a commitment to discovering novel antiviral agents. This product is designed to help the global scientific community better cope with diseases, including respiratory syncytial virus (RSV) and hepatitis B virus (HBV), among others.
To stay updated on the share price of ENTA, add it to your eToro watchlist.